Business Continuity Risk from Natural Disasters and COVID-19
First written in FY2022. 4 of 6 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2020: 67 of 114 companies on the "Worse" side.
101 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new major risks or significant changes to the business risks described in the annual securities report that management recognized as potentially having a material effect on the financial position, operating results, or cash flows of the consolidated companies, among the matters concerning business conditions and financial matters described in this Semiannual Report.」
The Company states that there have been no material changes in the business continuity risks associated with natural disasters and infectious diseases. - FY2025RestatedAnnual report
「The Group is developing a crisis-management framework and taking measures in preparation for emergencies. However, if a natural disaster such as a typhoon, earthquake, tsunami or infectious disease outbreak occurs on a scale far exceeding expectations, it may affect the business activities of the Group or its business partners.」
The disclosure continues to address business continuity risks from natural disasters and infectious diseases generally, rather than focusing on COVID-19. - FY2024-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The Company states that there have been no material changes in the business continuity risks associated with natural disasters and infectious diseases. - FY2024-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The Company states that there have been no material changes in the business continuity risks associated with natural disasters and infectious diseases. - FY2023ReframedAnnual report
「To address risks associated with the occurrence and spread of infectious diseases, the Group is strengthening its operational foundation by developing and enhancing remote-work environments, promoting online internal communication, providing all employees with opportunities for vaccination and other preventive measures, and thoroughly communicating policies on working when infection is suspected or when employees are unwell.」
The disclosure was reorganized from a focus specifically on COVID-19 to a description of business continuity risks from infectious diseases generally and countermeasures such as remote work and vaccinations. - FY2022First statedAnnual report
「At present, the spread of COVID-19 has not had a material effect on the Group's business operations or results of operations. However, if COVID-19 causes changes in the business environment that the Group has not anticipated and prevents its business operations from proceeding as planned, it may affect the Group's results of operations and financial condition.」
The Company identifies as risks the effects of natural disasters and infectious diseases on its own business activities and those of its business partners. It states that COVID-19 has not had a material effect at present.